Moderna shares tanked after research data was leaked, but Georgina Long says it still represents a ‘foundational shift’ in melanoma treatment.
Georgina Long, the Australian scientist overseeing a breakthrough new cancer vaccine, has dismissed negative investor reaction to leaked results of clinical trials, saying the treatments will dramatically cut the risk of melanoma recurring in patients.
Long compared the impact the development of a personalised melanoma vaccine would have on treating cancer to the way the invention of email transformed communications.
Gift articles to anyone you choose each month when you subscribe.
Compare how 6 other independent news outlets reported on this story.
Researchers have been chasing the dream of a cancer vaccine for decades. Some recent successes with mRNA technology are garnering excitement from patients, doctors, government and investors.
A cancer vaccine has cut patients' risk of death by 42% in a global clinical trial
The vaccine that protects Australians from a serious bacterial infection is expected to run out this week.
Men aged 50–69 and at average risk should get PSA screening every two years.
Paris-based Orakl Oncology has raised a $34M Series A to predict how cancer drugs will perform, using lab-grown copies of patients' tumours and AI.
One of the leading cancer organizations in the United States is raising the alarm over prostate cancer and directly urging men to get screened.
